“In this case-series, 67 patients who underwent HBOT for late radiation tissue injury after breast cancer reported significant improvement in pain, fibrosis, edema, and shoulder movement. The improvement persisted up to 12 months after HBOT” <view study> Read Less

The combination of metabolically supported chemotherapy, together with a ketogenic diet, hyperthermia and HBOT, appears to be promising in the treatment of advanced gastric cancer. <view study> Read Less

The results suggest that preconditioning with hyperbaric oxygen therapy can attenuate peripheral neuropathy caused by cisplatin in rats <view study> Read Less

A prospective observational study was conducted on 10 patients with lymphedema (breast cancer related — BCRL). Bioimpedance spectroscopy (a relatively new diagnostic tool for evaluating the severity of the lymphedema) confirmed the benefits of Hyperbaric oxygen therapy alongside conventional therapy <view study> Read Less

Triple-negative breast cancer (TNBC) is considered to be one of the more aggressive types of breast cancer, and is typically treated with chemotherapy. Cancers like these that are able to rapidly grow and spread are a major concern and need to be treated with an equally aggressive solution. This is why we are seeing more research and clinical trials utilizing combination therapies in order to help intensify the cytotoxic effects of chemotherapy in an aggressive measure to counteract these highly metastatic cancers. This report followed a 29 year old female that was put on an aggressive combination of chemotherapy, hyperthermia therapy, hyperbaric oxygen therapy, and a ketogenic diet. The results were remarkable and “presents evidence of a complete clinical, radiological, and pathological response following a six-month treatment period using this novel combination therapy in a patient with stage IV TNBC” <view study> Read Less